Literature DB >> 18037497

A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report.

Charlene J Bryan1, Thomas J Songer, Maria Mori Brooks, Michael E Thase, Bradley N Gaynes, Michael Klinkman, A John Rush, Madhukar H Trivedi, Maurizio Fava, Stephen R Wisniewski.   

Abstract

BACKGROUND: Patients with major depressive disorder (MDD) have high rates of medical comorbidities which can impair MDD treatment. Yet little is known regarding associations between the presence of a serious comorbidity and MDD treatment. The purpose of this study was to examine the baseline sociodemographic and clinical characteristics of MDD outpatients with and without diabetes mellitus to evaluate possible associations between these characteristics and the presence of comorbid diabetes.
METHODS: We gathered baseline sociodemographic and clinical data for 4041 participants with non-psychotic MDD who enrolled in the STAR*D, a large-scale depression treatment protocol, and made comparisons between participants with and without diabetes.
RESULTS: Participants with diabetes were more likely to be male, older, black, Hispanic, unemployed, and have less education, a lower income, higher mental functioning, lower physical functioning, atypical features, increased appetite, psychomotor slowing and leaden paralysis, and were less likely to have concurrent alcohol abuse/dependence, mood reactivity or problems with concentration. We found no significant differences between groups regarding depression severity. LIMITATIONS: The primary limitation is the lack of a clinical diagnosis of diabetes.
CONCLUSIONS: We found no difference in depression severity between participants with and without diabetes. Diabetes was associated with physical symptoms of depression. Thus treatments for these participants should be directed toward these symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 18037497     DOI: 10.1016/j.jad.2007.10.003

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

Review 1.  Psychomotor retardation in depression: biological underpinnings, measurement, and treatment.

Authors:  Jeylan S Buyukdura; Shawn M McClintock; Paul E Croarkin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-10-31       Impact factor: 5.067

2.  Relationship between Opium Abuse and Severity of Depression in Type 2 Diabetic Patients.

Authors:  Sepehrmanesh Zahra; Sarmast Hossein; Kord Valeshabad Ali
Journal:  Diabetes Metab J       Date:  2012-04-17       Impact factor: 5.376

3.  Motor abnormalities, depression risk, and clinical course in adolescence.

Authors:  Katherine S F Damme; Jadyn S Park; Teresa Vargas; Sebastian Walther; Stewart A Shankman; Vijay A Mittal
Journal:  Biol Psychiatry Glob Open Sci       Date:  2021-07-03

4.  Do depressed patients with diabetes experience more side effects when treated with CitalopramThan their counterparts without diabetes? a STAR*D study.

Authors:  Charlene Bryan; Thomas Songer; Maria Mori Brooks; Michael E Thase; Bradley Gaynes; Michael Klinkman; G K Balasubramani; A John Rush; Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 5.  Review of Cohort Studies for Mood Disorders.

Authors:  Hong Jin Jeon; Ji Hyun Baek; Yong-Min Ahn; Se Joo Kim; Tae Hyun Ha; Boseok Cha; Eunsoo Moon; Hee-Ju Kang; Vin Ryu; Chul-Hyun Cho; Jung-Yoon Heo; Kiwon Kim; Heon-Jeong Lee
Journal:  Psychiatry Investig       Date:  2016-05-18       Impact factor: 2.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.